SELIHEP

Of course starting these critical meds in the hospital is superior, people often fall thru the cracks. Too bad US Hospitals don’t like to administer expensive drugs during hospitalization.

People don’t achieve HCV cure if they don’t start treatment. The implementation gap addressed just today in @nytimes by Dr Collins nytimes.com/2023/11/28/opi…

Loved starting two patients on Mavyret inpatient last week! They were so excited to get started on treatment.

HCV TREATMENT: Start the Hepatitis C treatment while a patient is in the hospital (we do this and continue the whole time if PWID are being given 6 weeks of IV antibiotics for instance for osteomyelitis/endocarditis) - don't wait until outpatient setting. Like ART - start right away!

Remarkable RCT from Norway demonstrating that starting HCV treatment in the hospital with newly diagnosed HCV among PWIDs is superior to deferring therapy to outpatient care in achieving HCV cure. Results argue for broader use. @HMidgard @selihep doi.org/10.1093/cid/ci…

Inspiring work by inspiring people @Ane_Kristine @HMidgard @selihep - It's time to stop writing "hcv, defer to outpatient" in your consult notes, #idtwitter

Don’t put off until tomorrow what you can do today: Hospital admissions as an opportunity to treat hepatitis C ✅ Just Accepted 💬 Editorial Commentary 🔗 bit.ly/47nNWip

Opportunistic treatment of hepatitis C infection among hospitalized people who inject drugs (OPPORTUNI-C): A stepped wedge cluster randomized trial academic.oup.com/cid/article/do…

New study @AddictionJrnl finds incarcerated people had a massive (500%) reduction in overdose deaths in the 2 months post-release when receiving jail-based MOUD. Offering this life-saving treatment should be mandatory for jails and prisons nationally.

Poster at @INHepSU from @MajaSkaland highlighting that hospitalization is a great opportunity to test for hepatitis c! Awareness campaign improved test uptake, and we need to continue to inform and educate! #endhepc #eliminatehepc #INHSU22

@Oevrehusdk @SandraDroese @Cfritsyd Great work!

@SandraDroese poster at #INHSU2022 which I got to present. I matters to keep you records an don’t give up on lost to follow-up patients. 65 % entered treatment so far. @Cfritsyd

@INHepSU See u there!

Save the date! INHSU 2023 will take place in Geneva, Switzerland 🇨🇭 17-20 October. See you there 👋

Last session @INHepSU and grateful that the main result from Opportuni-C was highlighted in @tdbrothers rapporteur! @HMidgard

Thank you @SofiaRB_88 for your words! @INHepSU

People who use drugs cured of #hepc still has considerably higher mortality compared to the overall population! More knowledge is needed asap. @SofiaRB_88 @INHepSU

Great poster from Ben Eckhardt @nyulangone demonstrating fantastic #HCV treatment outcomes for young people who inject drugs (ST&RT study) #INHSU2022

Take home message from Kristian Malme today @INHepSU: Although HCV treatment uptake increased among people who inject drugs in 🇳🇴, strategies to improve treatment among women and individuals not engaged in OAT should be addressed!

Great morning session @INHepSU and we are ready for the last day of inspiration! #INHSU2022

There is no hard to reach patients- only hard to reach healthcare! #inhsu2022 @INHepSU

Just the best about @INHepSU . #INHSU2022 Engagement in all aspects from people with lived experience. It is health not “just” hepatitis.